These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 363253

  • 1. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
    Muss HB, White DR, Richards F, Cooper MR, Stuart JJ, Jackson DV, Rhyne L, Spurr CL.
    Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH, Catalano RB, Harris DT, Engstrom PF, Grotzinger PJ.
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [Abstract] [Full Text] [Related]

  • 4. A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.
    Smalley RV, Lefante J, Bartolucci A, Carpenter J, Vogel C, Krauss S.
    Breast Cancer Res Treat; 1983 Jan; 3(2):209-20. PubMed ID: 6688538
    [Abstract] [Full Text] [Related]

  • 5. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
    Hirshaut Y, Kesselheim H.
    Cancer; 1983 Jun 01; 51(11):1998-2004. PubMed ID: 6687698
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
    Aisner J, Weinberg V, Perloff M, Weiss R, Perry M, Korzun A, Ginsberg S, Holland JF.
    J Clin Oncol; 1987 Oct 01; 5(10):1523-33. PubMed ID: 3655855
    [Abstract] [Full Text] [Related]

  • 7. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).
    Carmo-Pereira J, Costa FO, Henriques E.
    Cancer; 1981 Oct 01; 48(7):1517-21. PubMed ID: 7026020
    [Abstract] [Full Text] [Related]

  • 8. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
    Pinnamaneni K, Yap HY, Buzdar AU, Distefano A, Blumenschein GR.
    Cancer; 1984 May 01; 53(9):1841-4. PubMed ID: 6546706
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy in advanced breast carcinoma. Comparison between doxorubicin-cyclophosphamide and cyclophosphamide-methotrexate-5-fluorouracil-vincristine-prednisone.
    Parvinen LM, Numminen S.
    Acta Radiol Oncol; 1985 May 01; 24(5):391-4. PubMed ID: 3002135
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
    Aisner J, Cirrincione C, Perloff M, Perry M, Budman D, Abrams J, Panasci L, Muss H, Citron M, Holland J.
    J Clin Oncol; 1995 Jun 01; 13(6):1443-52. PubMed ID: 7751891
    [Abstract] [Full Text] [Related]

  • 11. CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.
    Kolarić K, Roth A, Vukas D, Cervek J.
    Cancer Chemother Pharmacol; 1984 Jun 01; 13(2):142-4. PubMed ID: 6380789
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT, Boston B, Mitchell MS, Knobf MK, Bobrow SN, Pezzimenti JF, Lawrence R, Bertino JR.
    Cancer; 1978 Jul 01; 42(1):27-33. PubMed ID: 667798
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer.
    Rischin D, Bishop JF, Olver IN, Laidlaw CR, Zimet A, Jeal P, Dipell JF.
    Am J Clin Oncol; 1992 Oct 01; 15(5):392-4. PubMed ID: 1524039
    [Abstract] [Full Text] [Related]

  • 18. VP-16 and adriamycin in patients with advanced breast cancer.
    Vaughn CB, Maniscalco-Greb E, Lockhard C, Groshko G, Enochs K, Duffin H, Demitrish M.
    Am J Clin Oncol; 1982 Oct 01; 5(5):505-9. PubMed ID: 6897491
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.